Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ISOLAGEN INC | 150,000 | reported | 01 Mar 2016 | tx 2+370,000 |
| NewAmsterdam Pharma Co N.V. | 55,000 | reported | 01 Jun 2025 | tx 2+370,000 |
| NUPATHE INC. | 0 | reported | 21 Feb 2014 | tx 9+300,159−300,159 |
| OptiNose, Inc. | 0 | reported | 21 May 2025 | tx 70+1,602,478−329,509 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jun 2025 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 55,000 | — | |
| 01 Jun 2025 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 315,000 | 0.00 USD | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 125,204 | — | |
| 21 May 2025 | OTHER | OptiNose, Inc. | 3,056 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 9,333 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 9,626 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 5,775 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 5,500 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 10,575 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 5,333 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 12,350 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 16,752 | — | deriv |
| 18 Mar 2025 | SALE | OptiNose, Inc. | 246 | 5.61 USD | |
| 04 Mar 2025 | SALE | OptiNose, Inc. | 2,145 | 5.29 USD | |
| 21 Feb 2025 | GRANT_AWARD | OptiNose, Inc. | 21,150 | 0.00 USD | |
| 21 Feb 2025 | GRANT_AWARD | OptiNose, Inc. | 10,575 | 0.00 USD | deriv |
| 17 Dec 2024 | SALE | OptiNose, Inc. | 3,050 | 0.44 USD | |
| 17 Sept 2024 | SALE | OptiNose, Inc. | 3,226 | 0.87 USD | |
| 17 Jul 2024 | SALE | OptiNose, Inc. | 49,408 | 1.14 USD | |
| 18 Jun 2024 | SALE | OptiNose, Inc. | 2,946 | 1.19 USD | |
| 18 Jun 2024 | SALE | OptiNose, Inc. | 3,267 | 1.19 USD | |
| 15 Jun 2024 | GRANT_AWARD | OptiNose, Inc. | 3,817 | 0.00 USD | |
| 15 Mar 2024 | GRANT_AWARD | OptiNose, Inc. | 3,816 | 0.00 USD | |
| 18 Mar 2024 | SALE | OptiNose, Inc. | 15,059 | 1.88 USD | |
| 28 Feb 2024 | GRANT_AWARD | OptiNose, Inc. | 280,000 | 0.00 USD |